NIP
Nicholas Investment Partners Portfolio holdings
AUM
$1.12B
This Quarter Return
+30.1%
1 Year Return
+50.66%
3 Year Return
+286.38%
5 Year Return
+525.06%
10 Year Return
+2,262.45%
AUM
$1.29B
AUM Growth
+$1.29B
(+40%)
Cap. Flow
+$144M
Cap. Flow
% of AUM
11.09%
Top 10 Holdings %
Top 10 Hldgs %
19.69%
Holding
205
New
29
Increased
74
Reduced
24
Closed
25
Top Buys
| 1 |
ARNA
Arena Pharmaceuticals Inc
ARNA
|
$21.3M |
| 2 |
TG Therapeutics
TGTX
|
$20.7M |
| 3 |
Avantor
AVTR
|
$16.3M |
| 4 |
CELL
PhenomeX Inc. Common Stock
CELL
|
$12.1M |
| 5 |
Zai Lab
ZLAB
|
$12M |
Top Sells
| 1 |
IMMU
Immunomedics Inc
IMMU
|
$20.9M |
| 2 |
MYOK
MyoKardia, Inc. Common Stock
MYOK
|
$17.8M |
| 3 |
Twist Bioscience
TWST
|
$12.8M |
| 4 |
NovoCure
NVCR
|
$11.1M |
| 5 |
GBT
Global Blood Therapeutics, Inc.
GBT
|
$10.4M |
Sector Composition
| 1 | Healthcare | 48.02% |
| 2 | Technology | 12.16% |
| 3 | Consumer Discretionary | 8.78% |
| 4 | Industrials | 6.66% |
| 5 | Financials | 5.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
TG Therapeutics
TGTX
$4.65B
| $32.7M | 2.52% | 628,172 +398,720 | +174% | +$20.7M |
|
2
BridgeBio Pharma
BBIO
$9.89B
| $29.3M | 2.26% | 411,771 +118,789 | +41% | +$8.45M |
|
|
3
Twist Bioscience
TWST
$1.63B
| $25.3M | 1.95% | 178,875 -90,645 | -34% | -$12.8M |
|
4
Teladoc Health
TDOC
$1.37B
| $25.2M | 1.95% | 126,104 +32,704 | +35% | +$6.54M |
|
5
Repligen
RGEN
$6.88B
| $25M | 1.93% | 130,491 +290 | +0.2% | +$55.6K |
|
6
argenx
ARGX
$43.6B
| $24.5M | 1.89% | 83,328 -77 | -0.1% | -$22.6K |
|
7
Iovance Biotherapeutics
IOVA
$807M
| $23.6M | 1.82% | 507,651 +837 | +0.2% | +$38.8K |
|
|
8
NovoCure
NVCR
$1.38B
| $23.4M | 1.81% | 135,336 -64,277 | -32% | -$11.1M |
|
|
BHVN
9
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $23.2M | 1.79% | 270,362 +18,416 | +7% | +$1.58M |
|
10
Kornit Digital
KRNT
$669M
| $22.8M | 1.76% | 256,334 -13,820 | -5% | -$1.23M |
|
11
NeoGenomics
NEO
$1.13B
| $22.7M | 1.75% | 420,807 +717 | +0.2% | +$38.6K |
|
|
TPTX
12
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
| $22.4M | 1.73% | 183,676 +319 | +0.2% | +$38.9K |
|
13
Caesars Entertainment
CZR
$5.57B
| $22M | 1.7% | 295,852 +3,408 | +1% | +$253K |
|
|
ARNA
14
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $21.3M | 1.64% | +276,633 | New | +$21.3M |
|
|
HZNP
15
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $20.9M | 1.61% | 285,046 +20,690 | +8% | +$1.51M |
|
16
Monolithic Power Systems
MPWR
$40B
| $20.3M | 1.57% | 55,526 +247 | +0.4% | +$90.5K |
|
17
Exact Sciences
EXAS
$8.98B
| $20.1M | 1.55% | 151,746 +234 | +0.2% | +$31K |
|
18
Inspire Medical Systems
INSP
$2.77B
| $19.8M | 1.53% | 105,095 -1,018 | -1% | -$191K |
|
19
Schrodinger
SDGR
$1.44B
| $19.7M | 1.52% | 248,806 +12,983 | +6% | +$1.03M |
|
20
Guardant Health
GH
$8.41B
| $19.6M | 1.51% | 152,048 +13,948 | +10% | +$1.8M |
|
|
OSH
21
DELISTED
Oak Street Health, Inc.
OSH
| $18.6M | 1.43% | 303,407 +46,492 | +18% | +$2.84M |
|
22
Lattice Semiconductor
LSCC
$9.09B
| $18M | 1.39% | 392,706 -42,729 | -10% | -$1.96M |
|
23
Axsome Therapeutics
AXSM
$6.05B
| $16.9M | 1.31% | 207,452 +19,696 | +10% | +$1.6M |
|
|
24
Avantor
AVTR
$9.18B
| $16.3M | 1.26% | +579,037 | New | +$16.3M |
|
|
CELL
25
DELISTED
PhenomeX Inc. Common Stock
CELL
| $15.9M | 1.23% | 177,724 +135,440 | +320% | +$12.1M |
|